Pharmacist's Letter Canada

April 2018 Issue

Don't Think of A1C Goals as "One-Size-Fits-All"

Controversy is brewing about how to individualize A1C goals for adults with type 2 diabetes....

Resources

PL Voices: Individualizing A1C Goals
Commentary: A Personalized Approach for A1C Goals
Toolbox: Improving Diabetes Outcomes

Don't Jump to Belbuca Before Non-Opioids for Chronic Pain

The new Belbuca (bel-BYOO-kah) buccal film will raise questions about using buprenorphine for chronic pain....

Manage New Warnings About Clarithromycin and Cardiovascular Risk

Health Canada is investigating a possible link between clarithromycin and an increased risk of CV events or death....

Weigh Med Options to Manage Obesity

Contrave (CON-trayv) will be a new oral Rx combo to promote weight loss in obese or overweight patients....

GO TO FULL ISSUE

EDITOR's PICKS

Woman sneezing

BROWSE MORE RESOURCES

CE & Training

MORE CE COURSES

Popular Charts

Popular Patient Education Handouts

MED UPDATES

Ozanex
ozenoxacin
A nonfluorinated quinolone for topical treatment of impetigo.

Contrave
naltrexone/bupropion
An oral antiobesity agent indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in certain adults.

Belbuca
buprenorphine
New buccal film formulation for chronic pain management.

MORE MED UPDATES